These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 18171305)

  • 1. Hepatitis B virus and HIV coinfection in low-income countries: unmet needs.
    Puoti M; Manno D; Nasta P; Carosi G
    Clin Infect Dis; 2008 Feb; 46(3):367-9. PubMed ID: 18171305
    [No Abstract]   [Full Text] [Related]  

  • 2. Major causes of antiviral drug resistance and implications for treatment of hepatitis B virus monoinfection and coinfection with HIV.
    Locarnini S; Warner N
    Antivir Ther; 2007; 12 Suppl 3():H15-23. PubMed ID: 18284179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Special considerations and treatment of patients with HBV-HIV coinfection.
    Dieterich DT
    Antivir Ther; 2007; 12 Suppl 3():H43-51. PubMed ID: 18284182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Care of HIV patients with chronic hepatitis B: updated recommendations from the HIV-Hepatitis B Virus International Panel.
    Soriano V; Puoti M; Peters M; Benhamou Y; Sulkowski M; Zoulim F; Mauss S; Rockstroh J
    AIDS; 2008 Jul; 22(12):1399-410. PubMed ID: 18614862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis B and human immunodeficiency virus coinfection.
    Thio CL
    Hepatology; 2009 May; 49(5 Suppl):S138-45. PubMed ID: 19399813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular analysis of an HBsAg-negative hepatitis B virus mutant selected in a tenofovir-treated HIV-hepatitis B virus co-infected patient.
    Amini-Bavil-Olyaee S; Sheldon J; Lutz T; Trautwein C; Tacke F
    AIDS; 2009 Jan; 23(2):268-72. PubMed ID: 19098499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rational use of antiretroviral therapy in low-income and middle-income countries: optimizing regimen sequencing and switching.
    Elliott JH; Lynen L; Calmy A; De Luca A; Shafer RW; Zolfo M; Clotet B; Huffam S; Boucher CA; Cooper DA; Schapiro JM
    AIDS; 2008 Oct; 22(16):2053-67. PubMed ID: 18753937
    [No Abstract]   [Full Text] [Related]  

  • 8. Tenofovir-based rescue therapy for advanced liver disease in 6 patients coinfected with HIV and hepatitis B virus and receiving lamivudine.
    Gutiérrez S; Guillemi S; Jahnke N; Montessori V; Harrigan PR; Montaner JS
    Clin Infect Dis; 2008 Feb; 46(3):e28-30. PubMed ID: 18181733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Strategies for managing coinfection with hepatitis B virus and HIV.
    Sherman M
    Cleve Clin J Med; 2009 May; 76 Suppl 3():S30-3. PubMed ID: 19465707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic viral hepatitis may diminish the gains of HIV antiretroviral therapy in sub-Saharan Africa.
    Cooper CL; Mills E; Wabwire BO; Ford N; Olupot-Olupot P
    Int J Infect Dis; 2009 May; 13(3):302-6. PubMed ID: 19004656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV, hepatitis B and hepatitis C coinfection in Kenya.
    Harania RS; Karuru J; Nelson M; Stebbing J
    AIDS; 2008 Jun; 22(10):1221-2. PubMed ID: 18525268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. European AIDS Clinical Society (EACS) guidelines for the clinical management and treatment of chronic hepatitis B and C coinfection in HIV-infected adults.
    Rockstroh JK; Bhagani S; Benhamou Y; Bruno R; Mauss S; Peters L; Puoti M; Soriano V; Tural C;
    HIV Med; 2008 Feb; 9(2):82-8. PubMed ID: 18257771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of entecavir for chronic HBV in HIV/HBV coinfected patients receiving lamivudine as part of antiretroviral therapy.
    Pessôa MG; Gazzard B; Huang AK; Brandão-Mello CE; Cassetti I; Mendes-Corrêa MC; Soriano V; Phiri P; Hall A; Brett-Smith H
    AIDS; 2008 Sep; 22(14):1779-87. PubMed ID: 18753861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risks and benefits of using antiretroviral therapy in HIV-infected patients with chronic hepatitis B in developing regions.
    Soriano V; Rivas P; Nuñez M
    Clin Infect Dis; 2008 Dec; 47(11):1486-9. PubMed ID: 18937578
    [No Abstract]   [Full Text] [Related]  

  • 15. Hepatitis B virus and HIV coinfections can be interpreted in different ways.
    Alavian SM
    J Infect Chemother; 2013 Feb; 19(1):183. PubMed ID: 22886448
    [No Abstract]   [Full Text] [Related]  

  • 16. [Therapy of HIV-HBV-coinfection].
    Mauss S
    MMW Fortschr Med; 2009 Apr; 151(18):49-50, 52-3. PubMed ID: 19769076
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment of chronic hepatitis B and the implications of viral resistance to therapy.
    Mauss S; Wedemeyer H
    Expert Rev Anti Infect Ther; 2008 Apr; 6(2):191-9. PubMed ID: 18380601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of chronic hepatitis B].
    Mauss S
    MMW Fortschr Med; 2008 Apr; 150 Spec No 1():48-51. PubMed ID: 19031564
    [No Abstract]   [Full Text] [Related]  

  • 19. [Chronic HBeAg-negative viral gepatitis B: treatment is essential and possible].
    Isakov VA
    Eksp Klin Gastroenterol; 2007; (5):40-5. PubMed ID: 18389596
    [No Abstract]   [Full Text] [Related]  

  • 20. The pathogenesis of liver disease in the setting of HIV-hepatitis B virus coinfection.
    Iser DM; Lewin SR
    Antivir Ther; 2009; 14(2):155-64. PubMed ID: 19430090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.